MeSH term | MeSH ID | Detail |
---|---|---|
Sacroiliitis | D058566 | 1 associated lipids |
Chlamydial Pneumonia | D061387 | 2 associated lipids |
clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with clarithromycin
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Sillakivi T et al. | An attempt at Helicobacter pylori eradication with intravenous clarithromycin in perforated peptic ulcer patients. | 2001 | Scand. J. Gastroenterol. | pmid:11589389 |
Tulassay Z et al. | Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers. | 2010 | Scand. J. Gastroenterol. | pmid:20509752 |
Marignani M et al. | Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection. | 1997 | Scand. J. Gastroenterol. | pmid:9200297 |
Valooran GJ et al. | Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure. | 2011 | Scand. J. Gastroenterol. | pmid:21627398 |
Kajihara Y et al. | Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. | 2017 | Scand. J. Gastroenterol. | pmid:27806639 |
Ogura K et al. | Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given? | 2001 | Scand. J. Gastroenterol. | pmid:11424316 |
Hojo M et al. | Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection. | 2001 | Scand. J. Gastroenterol. | pmid:11444467 |
Giorgio F et al. | Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis. | 2016 | Scand. J. Gastroenterol. | pmid:27687850 |
Ashorn M et al. | Helicobacter pylori and iron deficiency anaemia in children. | 2001 | Scand. J. Gastroenterol. | pmid:11444468 |
Masuda H et al. | Necessity of multiple gastric biopsies from different sites for detection of clarithromycin-resistant Helicobacter pylori strains. | 2003 | Scand. J. Gastroenterol. | pmid:14531530 |
Ellenrieder V et al. | Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. | 1999 | Scand. J. Gastroenterol. | pmid:10499474 |
Ochi M et al. | Regression of primary low-grade mucosa-associated lymphoid tissue lymphoma of duodenum after long-term treatment with clarithromycin. | 2006 | Scand. J. Gastroenterol. | pmid:16497629 |
Unge P et al. | Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features? | 2003 | Scand. J. Gastroenterol. | pmid:12795457 |
de Boer WA and Tytgat GN | The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? | 1995 | Scand. J. Gastroenterol. | pmid:7638563 |
Seppälä K et al. | Cure of Helicobacter pylori infection in all compliant patients: report on 644 subjects. | 2008 | Scand. J. Gastroenterol. | pmid:18609180 |
Befrits R et al. | Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study. | 2004 | Scand. J. Gastroenterol. | pmid:15545163 |
Khan Z et al. | Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study. | 2002 | Scand. J. Gastroenterol. | pmid:11843048 |
Gasbarrini A et al. | Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. | 2000 | Scand. J. Gastroenterol. | pmid:10766318 |
Fiorini G et al. | Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016. | 2018 | Scand. J. Gastroenterol. | pmid:29688095 |
Zevit N et al. | Antibiotic resistance of Helicobacter pylori in Israeli children. | 2010 | Scand. J. Gastroenterol. | pmid:20199338 |
Abut E et al. | Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study. | 2010 | Scand. J. Gastroenterol. | pmid:20334478 |
Pedrazzoli J et al. | Transfer of clarithromycin to gastric juice is enhanced by omeprazole in Helicobacter pylori-infected individuals. | 2001 | Scand. J. Gastroenterol. | pmid:11761012 |
Li H et al. | Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study. | 2018 | Scand. J. Gastroenterol. | pmid:29214879 |
Lindsetmo RO et al. | Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy. | 1998 | Scand. J. Gastroenterol. | pmid:9548613 |
Raymond J et al. | Diagnosis of Helicobacter pylori recurrence: relapse or reinfection? Usefulness of molecular tools. | 2016 | Scand. J. Gastroenterol. | pmid:26784882 |
Lerang F et al. | Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. | 1997 | Scand. J. Gastroenterol. | pmid:9438318 |
Seppälä K et al. | Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients. | 2000 | Scand. J. Gastroenterol. | pmid:11063151 |
Higashida A et al. | Effectiveness of esomeprazole-based triple therapy of H. pylori in young patients in Japan. | 2013 | Scand. J. Gastroenterol. | pmid:23016956 |
Testoni PA and Bagnolo F | In dyspeptic patients without gastric phase III of the migrating motor complex, Helicobacter pylori eradication produces no short-term changes in interdigestive motility pattern. | 2000 | Scand. J. Gastroenterol. | pmid:10994618 |
Di Giulio M et al. | In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. | 2016 | Scand. J. Gastroenterol. | pmid:26554617 |
Lee JW et al. | A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea. | 2014 | Scand. J. Gastroenterol. | pmid:24988873 |
Cellini L et al. | Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. | 2006 | Scand. J. Gastroenterol. | pmid:16497614 |
Lee JW et al. | GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea. | 2014 | Scand. J. Gastroenterol. | pmid:24957849 |
Tepes B | Comparison of two invasive diagnostic tests for Helicobacter pylori after antimicrobial therapy. | 2007 | Scand. J. Gastroenterol. | pmid:17354112 |
Gisbert JP et al. | Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection. | 2013 | Scand. J. Gastroenterol. | pmid:23556551 |
Gisbert JP et al. | Unhealed duodenal ulcers despite Helicobacter pylori eradication. | 1997 | Scand. J. Gastroenterol. | pmid:9246702 |
Parente F et al. | Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study. | 1998 | Scand. J. Gastroenterol. | pmid:9648983 |
Apostolopoulos P et al. | Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study. | 2016 | Scand. J. Gastroenterol. | pmid:26435055 |
Doorakkers E et al. | Helicobacter pylori eradication in the Swedish population. | Scand. J. Gastroenterol. | pmid:28323552 | |
Tsukada K et al. | Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients. | 2002 | Scand. J. Gastroenterol. | pmid:12465723 |
Murakami K et al. | Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study. | 2011 | Scand. J. Gastroenterol. | pmid:21073372 |
Ribaldone DG et al. | Helicobacter pylori eradication: poor medical compliance from East to West of the world. | 2018 | Scand. J. Gastroenterol. | pmid:29383955 |
Farup PG et al. | Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. | 2002 | Scand. J. Gastroenterol. | pmid:12523585 |
Götz JM et al. | Triple therapy with ranitidine, clarithromycin, and metronidazole in the treatment of Helicobacter pylori. | 1995 | Scand. J. Gastroenterol. Suppl. | pmid:8578230 |
Williamson R et al. | New options in Helicobacter pylori eradication: efficacy, resistance and synergy. | 1998 | Scand. J. Gastroenterol. Suppl. | pmid:9515751 |
Unge P | Review of Helicobacter pylori eradication regimens. | 1996 | Scand. J. Gastroenterol. Suppl. | pmid:8722388 |
Bazzoli F | Italian omeprazole triple therapy--a 1-week regimen. | 1996 | Scand. J. Gastroenterol. Suppl. | pmid:8722395 |
Alfakry H et al. | Periodontopathogen- and host-derived immune response in acute coronary syndrome. | 2011 | Scand. J. Immunol. | pmid:21645027 |
Alfakry H et al. | The association of serum neutrophil markers and acute coronary syndrome. | 2012 | Scand. J. Immunol. | pmid:22537345 |
Hakawi AM and Alrajhi AA | Septic arthritis due to Mycobacterium szulgai in a patient with human immunodeficiency virus: case report. | 2005 | Scand. J. Infect. Dis. | pmid:15849060 |